ESMO ranking of the clinical benefits of new drugs

Back to work: employment protections for patients and their families

Cancer and the workplace

The recent past and near future of drug approvals in Europe

Informed patients are empowered patients

Europa Uomo - improving prostate cancer patients quality of life across Europe

ECCO: making cross-border cancer healthcare a reality

Working With Cancer: helping people affected by cancer return to work

Treating the patient, not the disease: in memory of Umberto Veronesi

ShortHER trastuzumab treatment of HER2 breast cancer: 9 weeks v 1 year

Prevalence of homologous recombination deficiency among 53,000 tumour samples

Natural plant based balm antidote to severe nail toxicity during chemotherapy